LncRNA-PRLB drives ovarian cancer progression and chemoresistance by stabilizing GPX4 mRNA through the FUS-mediated suppression of ferroptosis.
Saved in:
| Title: | LncRNA-PRLB drives ovarian cancer progression and chemoresistance by stabilizing GPX4 mRNA through the FUS-mediated suppression of ferroptosis. |
|---|---|
| Authors: | Jiang L; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Pi J; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China., Li N; Department of Obstetrics and Gynecology, Jiayu County Maternal and Child Health Hospital, Jiayu, Hubei, China., Cao J; Department of Obstetrics and Gynecology, Wuhan Caidian District Maternal and Child Health Hospital of Wuhan, Wuhan, China., Zhao Y; Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, China. |
| Source: | Frontiers in medicine [Front Med (Lausanne)] 2026 Feb 17; Vol. 13, pp. 1759058. Date of Electronic Publication: 2026 Feb 17 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2296-858X |
|---|---|
| DOI: | 10.3389/fmed.2026.1759058 |
